A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study).
Saved in:
| Title: | A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study). |
|---|---|
| Authors: | Oh DY; Division of Medical Oncology, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea. ohdoyoun@snu.ac.kr., Yeo W; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong., Chen JS; Department of Hematology-Oncology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan., Ba Y; Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Cancer Medical Center & Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China., Chan WWL; Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong., Chen MJ; Department of Gastroenterology, MacKay Memorial Hospital, Taipei, Taiwan., Chen YH; Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Gu K; Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Hung YP; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Kim JG; Division of Hemato-oncology, Kyungpook National University Chilgok Hospital, Daegu, Korea., Lee J; Department of Hematology and Oncology, Samsung Medical Center, Seoul, Korea., Liang X; Medical Oncology, Hubei Cancer Hospital, Wuhan, China., Luo S; Department of Medical Oncology, Henan Cancer Hospital, Zhengzhou, China., Rha SY; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Yuan Y; Department of Medical Oncology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China., Kim T; STAT Team, Linical Korea, Seoul, Korea., Yanagida M; Medical Affairs Group, ASCA Oncology Product Department, ASCA Business Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Sato R; Medical Affairs Group, ASCA Oncology Product Department, ASCA Business Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Xu RH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. |
| Source: | Cancer research and treatment [Cancer Res Treat] 2026 Jun 22. Date of Electronic Publication: 2026 Jun 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
